All stories tagged biotech on VentureGrill.
Max Hodak's Science Corporation has implanted its vision-restoring chip in a Stargardt disease patient, marking a critical clinical milestone for the Neuralink co-founder's new venture and setting a new benchmark for BCI investment. The move underscores the intense capital alloca
Trilantic North America realizes a $945 million exit with the sale of SOFIE Biosciences, capitalizing on surging strategic buyer appetite in the radiopharmaceuticals sector.
Evvy's $40 million Series B round, led by biotech investor Catalio Capital Management, signals a broader venture shift from consumer wellness apps to high-margin clinical diagnostics.
Electra Therapeutics raises $350 million in an upsized IPO, but a flat opening day underscores the cooling appetite for high-burn clinical-stage biotech assets.
Global venture funding into biotech startups has maintained a consistent trajectory, hovering between $36 billion and $40 billion annually, even as AI investment experiences dramatic shifts.
Vijay Pande, formerly leading a $4 billion biotech practice at a16z, has launched VZVC, a new AI-native fund focused on 'smaller bets,' signaling a strategic pivot in venture capital's approach to biotech innovation.
A classic $2 million seed round is no longer the default. New data shows early-stage venture capital is clustering into $5 million to $10 million 'mega-seeds' for deep tech, space, and biotech.
Miles Wang, an OpenAI researcher, is in talks to launch an AI-driven drug discovery startup valued at $2 billion, signaling strong investor appetite for AI applications in life sciences.